Literature DB >> 29218654

miR-200c as a Predictive Biomarker for 5-Fluorouracil Chemosensitivity in Colorectal Cancer.

Fatemeh Karimi Dermani1, Rezvan Najafi2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29218654     DOI: 10.1007/s12029-017-0038-3

Source DB:  PubMed          Journal:  J Gastrointest Cancer


× No keyword cloud information.
  11 in total

Review 1.  Role of microRNA in anticancer drug resistance.

Authors:  Tongsen Zheng; Jiabei Wang; Xi Chen; Lianxin Liu
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

2.  Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.

Authors:  T Ranjbarnejad; M Saidijam; M Sadat Tafakh; M Pourjafar; F Talebzadeh; R Najafi
Journal:  Hum Exp Toxicol       Date:  2016-08-01       Impact factor: 2.903

3.  Induction of epithelial-mesenchymal transition and down-regulation of miR-200c and miR-141 in oxaliplatin-resistant colorectal cancer cells.

Authors:  Shota Tanaka; Mika Hosokawa; Takeshi Yonezawa; Wataru Hayashi; Kumiko Ueda; Seigo Iwakawa
Journal:  Biol Pharm Bull       Date:  2014-12-27       Impact factor: 2.233

4.  miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.

Authors:  Yong Chen; Ying Sun; Longbang Chen; Xingxiang Xu; Xizhi Zhang; Buhai Wang; Lingfeng Min; Wei Liu
Journal:  Mol Med Rep       Date:  2013-03-28       Impact factor: 2.952

5.  The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.

Authors:  Korosh Heydari; Massoud Saidijam; Mohammad Reza Sharifi; Fatemeh Karimi Dermani; Sara Soleimani Asl; Nooshin Shabab; Rezvan Najafi
Journal:  Pathol Oncol Res       Date:  2017-04-14       Impact factor: 3.201

6.  Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

Authors:  Shusuke Toden; Yoshinaga Okugawa; Thomas Jascur; Dominik Wodarz; Natalia L Komarova; Constanze Buhrmann; Mehdi Shakibaei; C Richard Boland; Ajay Goel
Journal:  Carcinogenesis       Date:  2015-02-04       Impact factor: 4.944

Review 7.  MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment.

Authors:  Parham Jabbarzadeh Kaboli; Asmah Rahmat; Patimah Ismail; King-Hwa Ling
Journal:  Pharmacol Res       Date:  2015-05-07       Impact factor: 7.658

8.  Resveratrol Inhibits Proliferation, Invasion, and Epithelial-Mesenchymal Transition by Increasing miR-200c Expression in HCT-116 Colorectal Cancer Cells.

Authors:  Fatemeh Karimi Dermani; Massoud Saidijam; Razieh Amini; Ali Mahdavinezhad; Korosh Heydari; Rezvan Najafi
Journal:  J Cell Biochem       Date:  2016-12-13       Impact factor: 4.429

9.  miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.

Authors:  Tao Li; Feng Gao; Xi-Peng Zhang
Journal:  Oncol Rep       Date:  2014-12-04       Impact factor: 3.906

Review 10.  MiR-200, a new star miRNA in human cancer.

Authors:  Xiangling Feng; Zhengming Wang; Rebecca Fillmore; Yaguang Xi
Journal:  Cancer Lett       Date:  2013-11-19       Impact factor: 8.679

View more
  1 in total

1.  Predominant Distribution of the RNAi Machinery at Apical Adherens Junctions in Colonic Epithelia Is Disrupted in Cancer.

Authors:  Joyce Nair-Menon; Amanda C Daulagala; Dean M Connor; Lauren Rutledge; Trevor Penix; Mary Catherine Bridges; Bridgette Wellslager; Demetri D Spyropoulos; Cynthia D Timmers; Ann-Marie Broome; Antonis Kourtidis
Journal:  Int J Mol Sci       Date:  2020-04-07       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.